JPH06340622A - Production of benzylsuccinic acid derivative and intermediate for its synthesis - Google Patents
Production of benzylsuccinic acid derivative and intermediate for its synthesisInfo
- Publication number
- JPH06340622A JPH06340622A JP16585293A JP16585293A JPH06340622A JP H06340622 A JPH06340622 A JP H06340622A JP 16585293 A JP16585293 A JP 16585293A JP 16585293 A JP16585293 A JP 16585293A JP H06340622 A JPH06340622 A JP H06340622A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- acid derivative
- benzylsuccinic acid
- benzyl
- succinic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GTOFKXZQQDSVFH-UHFFFAOYSA-N 2-benzylsuccinic acid Chemical class OC(=O)CC(C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 title claims description 23
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 ethylene, trimethylene, o-phenylene Chemical group 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 claims description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 3
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 238000005406 washing Methods 0.000 abstract description 2
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229940125708 antidiabetic agent Drugs 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- GTOFKXZQQDSVFH-VIFPVBQESA-N (r)-2-benzylsuccinate Chemical compound OC(=O)C[C@@H](C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-VIFPVBQESA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- WPGGHFDDFPHPOB-BBWFWOEESA-N mitiglinide Chemical compound C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)O)C1=CC=CC=C1 WPGGHFDDFPHPOB-BBWFWOEESA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- ODSNARDHJFFSRH-OCAPTIKFSA-N (3as,7ar)-2,3,3a,4,5,6,7,7a-octahydro-1h-isoindole Chemical compound C1CCC[C@@H]2CNC[C@@H]21 ODSNARDHJFFSRH-OCAPTIKFSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- PFYXSUNOLOJMDX-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)ON1C(=O)CCC1=O PFYXSUNOLOJMDX-UHFFFAOYSA-N 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003443 succinic acid derivatives Chemical class 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- OFJWFSNDPCAWDK-UHFFFAOYSA-N 2-phenylbutyric acid Chemical class CCC(C(O)=O)C1=CC=CC=C1 OFJWFSNDPCAWDK-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- BTOJSYRZQZOMOK-UHFFFAOYSA-N 4-chloro-7-(4-methylphenyl)sulfonylpyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C2=NC=NC(Cl)=C2C=C1 BTOJSYRZQZOMOK-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- BIMFYTDURNQXQN-ZDUSSCGKSA-N bis(2,5-dioxopyrrolidin-1-yl) (2S)-2-benzylbutanedioate Chemical compound C([C@@H](CC(=O)ON1C(CCC1=O)=O)C(=O)ON1C(CCC1=O)=O)C1=CC=CC=C1 BIMFYTDURNQXQN-ZDUSSCGKSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 1
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- ZUSSTQCWRDLYJA-UHFFFAOYSA-N n-hydroxy-5-norbornene-2,3-dicarboximide Chemical compound C1=CC2CC1C1C2C(=O)N(O)C1=O ZUSSTQCWRDLYJA-UHFFFAOYSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は医薬品として有用なベン
ジルコハク酸誘導体の製造方法およびその製造中間体に
関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a benzylsuccinic acid derivative useful as a medicine and an intermediate for producing the same.
【0002】さらに詳しく述べれば、本発明は血糖低下
作用を有し、糖尿病治療薬として有用な、式More specifically, the present invention has a hypoglycemic effect and is useful as a therapeutic drug for diabetes.
【0003】[0003]
【化4】 [Chemical 4]
【0004】(式中の(S)を付した炭素原子の配置は
S配置を示す)で表されるベンジルコハク酸誘導体を簡
便かつ高収率で製造する方法およびその製造中間体に関
するものである。The present invention relates to a method for producing a benzyl succinic acid derivative represented by the formula (the arrangement of carbon atoms marked with (S) shows the S arrangement) conveniently and in high yield, and an intermediate for producing the same. .
【0005】[0005]
【従来の技術】前記式(I)で表されるベンジルコハク
酸誘導体の合成方法として、例えば、特開平4−356
459号においては、一般式2. Description of the Related Art As a method for synthesizing a benzylsuccinic acid derivative represented by the above formula (I), for example, JP-A-4-356 is known.
In No. 459, the general formula
【0006】[0006]
【化5】 [Chemical 5]
【0007】(式中のRは炭素数1〜6のアルキル基、
炭素数7〜10のアラルキル基またはその他のカルボキ
シル基の保護基であり、*を付した炭素原子の配置はR
配置、S配置またはそれらが混合した配置を示す)で表
されるフェニル酪酸誘導体またはその反応性官能的誘導
体と、式(Wherein R is an alkyl group having 1 to 6 carbon atoms,
It is a protecting group for an aralkyl group having 7 to 10 carbon atoms or other carboxyl group, and the arrangement of carbon atoms marked with * is R
Configuration, S-configuration or a mixed configuration thereof), a phenylbutyric acid derivative or a reactive functional derivative thereof, and a formula
【0008】[0008]
【化6】 [Chemical 6]
【0009】で表される環状アミンとを反応させ、次い
で必要に応じ低級アルキル基、アラルキル基などの保護
基を除去することにより製造できる方法が示されている
が、一方のカルボキシル基のみに保護基が導入された一
般式(II)で表される中間体を製造すること自体工程
数が長く収率の低い方法であり、さらに、カルボキシル
基の保護基を除去する際に高価な触媒を用いた接触水添
などを行わなければならず、工業的生産に適当な方法と
は言えないものであった。A method which can be prepared by reacting with a cyclic amine represented by and then removing a protecting group such as a lower alkyl group and an aralkyl group is shown, but only one carboxyl group is protected. The production of an intermediate represented by the general formula (II) in which a group is introduced is a method which itself has a long number of steps and a low yield, and further, an expensive catalyst is used when removing the protecting group of the carboxyl group. The contact hydrogenation has to be carried out, which is not a suitable method for industrial production.
【0010】それゆえ、本発明の前記式(1)で表され
る光学活性なベンジルコハク酸誘導体を簡便かつ高収率
で製造することができ、工業的生産に適用できる方法を
見出すことが強く望まれていた。Therefore, it is strongly desired to find a method which can produce the optically active benzylsuccinic acid derivative represented by the above formula (1) of the present invention simply and in high yield, and can be applied to industrial production. Was wanted.
【0011】[0011]
【発明が解決しようとする課題】本発明の目的は血糖低
下作用を有し、糖尿病治療剤として有用な光学活性なベ
ンジルコハク酸誘導体の簡便かつ高収率な製造方法およ
びその製造中間体を提供することである。The object of the present invention is to provide a simple and high-yield production method of an optically active benzylsuccinic acid derivative having a hypoglycemic action and useful as a therapeutic agent for diabetes, and an intermediate thereof. It is to be.
【0012】[0012]
【課題を解決するための手段】本発明者らは上記課題を
解決すべく鋭意研究を重ねた結果、一般式[Means for Solving the Problems] As a result of intensive studies conducted by the present inventors to solve the above problems, the general formula
【0013】[0013]
【化7】 [Chemical 7]
【0014】(式中のAはエチレン基、トリメチレン
基、o−フェニレン基またはビシクロ〔2,2,1〕ヘ
プタ−5−エン−2,3−ジイル基であり、(S)を付
した炭素原子は前記と同じ意味をもつ)で表されるベン
ジルコハク酸誘導体のN−カルボニルオキシイミド基
が、極めて温和な条件で加水分解を受けて、カルボキシ
ル基に変換され、高収率で前記式(I)のベンジルコハ
ク酸誘導体を製造することができるという知見を得た。
さらに、加水分解反応の際脱離する、一般式(A in the formula is an ethylene group, a trimethylene group, an o-phenylene group or a bicyclo [2,2,1] hept-5-ene-2,3-diyl group, and a carbon having (S) attached thereto. The atom has the same meaning as above), the N-carbonyloxyimide group of the benzyl succinic acid derivative represented by the formula is hydrolyzed under extremely mild conditions to be converted into a carboxyl group, and the above formula ( It was found that the benzyl succinic acid derivative of I) can be produced.
Furthermore, a general formula that is eliminated during the hydrolysis reaction
【0015】[0015]
【化8】 [Chemical 8]
【0016】(式中のAは前記と同じ意味をもつ)で表
わされるN−ヒドロキシイミド誘導体は水に容易に溶解
する性質を有しているので、反応液を水で処理するとい
う簡単な操作で容易に除去することができるため、特別
な単離操作を行うことなく、目的の前記式(I)で表さ
れる化合物がほぼ純品として得られ、そのままあるいは
所望により塩とした後簡単な再結晶工程だけで医薬品と
して使用できる高純度のものを得ることができるという
知見を得、本発明を成すに至った。Since the N-hydroxyimide derivative represented by (A in the formula has the same meaning as described above) has a property of being easily dissolved in water, a simple operation of treating the reaction solution with water is performed. The compound of formula (I) of interest can be obtained as a pure product without any special isolation procedure, and can be easily removed as it is or after it is converted into a salt to give a simple product. The present invention has been completed based on the finding that a highly pure product that can be used as a drug can be obtained only by the recrystallization step.
【0017】すなわち、本発明の製造方法は、前記一般
式(IV)で表されるベンジルコハク酸誘導体を加水分
解することを特徴とする前記式(I)で表されるベンジ
ルコハク酸誘導体を得る方法である。That is, in the production method of the present invention, the benzyl succinic acid derivative represented by the above formula (I) is obtained by hydrolyzing the benzyl succinic acid derivative represented by the above general formula (IV). Is the way.
【0018】本製造方法において出発原料として用いら
れる前記一般式(IV)で表されるベンジルコハク酸誘
導体は文献未記載の新規化合物であり、例えば以下のよ
うな方法で製造することができる。すなわち、式The benzyl succinic acid derivative represented by the general formula (IV) used as a starting material in the present production method is a novel compound which has not been described in any literature, and can be produced, for example, by the following method. That is, the formula
【0019】[0019]
【化9】 [Chemical 9]
【0020】(式中の(S)を付した炭素原子は前記と
同じ意味をもつ)で表されるベンジルコハク酸とN,
N’−ジスクシンイミジルカルボネートなどの前記一般
式(V)で表わされるN−ヒドロキシイミド誘導体の反
応性誘導体とを反応させることにより、一般式Benzylsuccinic acid represented by the formula (wherein the carbon atom with (S) has the same meaning as described above) and N,
By reacting with a reactive derivative of the N-hydroxyimide derivative represented by the general formula (V) such as N′-disuccinimidyl carbonate, the general formula
【0021】[0021]
【化10】 [Chemical 10]
【0022】(式中のAおよび(S)を付した炭素原子
は前記と同じ意味をもつ)で表されるベンジルコハク酸
誘導体を得、次いでこれに式(III)で表される環状
アミンを反応させることによって製造することができ
る。前記一般式(VII)で表されるベンジルコハク酸
誘導体のN−カルボニルオキシイミド基は反応性が高
く、しかも選択性が高いので高純度で目的とする前記一
般式(IV)で表されるベンジルコハク酸誘導体が生成
する。従って、このようにして製造した出発原料の前記
一般式(IV)で表されるベンジルコハク酸誘導体は、
実際の製造においては特に単離精製する必要はなく、反
応混合物のまま、次の工程に供してもよい。A benzyl succinic acid derivative represented by the formula (wherein the carbon atoms with A and (S) have the same meanings as described above), and then the cyclic amine represented by the formula (III) is added thereto. It can be produced by reacting. Since the N-carbonyloxyimide group of the benzylsuccinic acid derivative represented by the general formula (VII) has high reactivity and high selectivity, the desired benzyl represented by the general formula (IV) can be obtained. A succinic acid derivative is produced. Therefore, the benzyl succinic acid derivative represented by the general formula (IV) as the starting material thus produced is
In the actual production, there is no particular need for isolation and purification, and the reaction mixture may be subjected to the next step as it is.
【0023】本製造方法をさらに詳細に説明すると、前
記式(VI)で表されるベンジルコハク酸から出発原料
の前記式(IV)で表されるベンジルコハク酸誘導体の
製造を含め、一貫して前記式(VI)で表されるベンジ
ルコハク酸から製造する場合、前記式(VI)で表され
るベンジルコハク酸とN,N’−ジスクシンイミジルカ
ルボネートなどの前記一般式(V)で表わされるN−ヒ
ドロキシイミド誘導体の反応性誘導体とを不活性溶媒
中、必要に応じ塩基性物質の存在下に反応させるか、前
記式(VI)で表わされるベンジルコハク酸と前記一般
式(V)で表わされるN−ヒドロキシイミド誘導体とを
縮合剤の存在下、不活性溶媒中、必要に応じ塩基性物質
の存在下反応させるか、または前記式(VI)で表わさ
れるベンジルコハク酸の反応性官能的誘導体と前記一般
式(V)で表わされるN−ヒドロキシイミド誘導体とを
不活性溶媒中、必要に応じ塩基性物質の存在下に反応さ
せることなどにより、前記一般式(VII)で表わされ
るベンジルコハク酸誘導体を製し、次いでこの前記一般
式(VII)で表わされるベンジルコハク酸誘導体とほ
ぼ等モル量の前記式(III)で表わされる環状アミン
とを不活性溶媒中−30℃から40℃、好ましくは室温
で、3時間から20時間、好ましくは数時間反応するこ
とにより前記一般式(IV)で表わされるベンジルコハ
ク酸誘導体を得る。本製造方法において前記式(VI
I)で表される製造中間体は単離、精製して次の工程の
製造原料としてもよいが、単離、精製することなく次の
工程に供しても何ら支障がなく、むしろ実際の工業生産
においてはそのまま次の工程に供した方が操作が簡便で
好ましい。The present production method will be described in more detail, including the production of the starting benzylsuccinic acid derivative of the formula (IV) from the benzylsuccinic acid of the formula (VI). When the benzyl succinic acid represented by the formula (VI) is used, the benzyl succinic acid represented by the formula (VI) and the general formula (V) such as N, N′-disuccinimidyl carbonate can be used. The reactive derivative of the represented N-hydroxyimide derivative is reacted in an inert solvent, if necessary, in the presence of a basic substance, or the benzyl succinic acid represented by the above formula (VI) and the above general formula (V) Or an benzyl succinic acid represented by the above formula (VI) in the presence of a condensing agent in an inert solvent in the presence of a basic substance, if necessary. And the N-hydroxyimide derivative represented by the general formula (V) are reacted in an inert solvent in the presence of a basic substance, if necessary, to obtain the general formula (VII). A benzyl succinic acid derivative of formula (VII) is prepared, and then the benzyl succinic acid derivative of formula (VII) and an approximately equimolar amount of the cyclic amine of formula (III) are mixed with each other in an inert solvent at −30. The benzyl succinic acid derivative represented by the general formula (IV) is obtained by reacting at -40 to 40 ° C., preferably room temperature for 3 to 20 hours, preferably several hours. In the production method, the above formula (VI
The production intermediate represented by I) may be isolated and purified to be used as a production raw material in the next step, but it can be used in the next step without isolation and purification without any problem, and rather, in an actual industrial process. In production, it is preferable that the product is directly subjected to the next step because the operation is simple.
【0024】このようにして得られた前記一般式(I
V)で表されるベンジルコハク酸誘導体を無溶媒または
溶媒中において0.5〜2規定、好ましくは1規定の水
酸化ナトリウム水溶液と、−30℃から40℃、好まし
くは室温で、数時間撹拌後、必要に応じ溶媒を留去後、
残留物を有機溶媒に溶かし水層を分離する。分離した水
層を酸性とし有機溶媒で抽出することにより容易に収率
よく光学純度の高い前記式(I)で表されるベンジルコ
ハク酸誘導体を製造できる。さらに所望により、前記式
(I)で表されるベンジルコハク酸誘導体を無機塩基あ
るいは有機アミンと処理することにより薬理学的に許容
される例えばカルシウム塩などの塩にすることができ
る。The above-mentioned general formula (I
The benzyl succinic acid derivative represented by V) is stirred with a 0.5 to 2N, preferably 1N aqueous sodium hydroxide solution without solvent or in a solvent at -30 to 40 ° C, preferably at room temperature for several hours. After that, after distilling off the solvent if necessary,
The residue is dissolved in an organic solvent and the aqueous layer is separated. By acidifying the separated aqueous layer and extracting with an organic solvent, the benzyl succinic acid derivative represented by the above formula (I) with high yield and high optical purity can be easily produced. Furthermore, if desired, the benzyl succinic acid derivative represented by the above formula (I) can be treated with an inorganic base or an organic amine to form a pharmacologically acceptable salt such as a calcium salt.
【0025】本製造方法の製造中間体の前記一般式(I
V)で表されるベンジルコハク酸誘導体は単離、精製し
て次の工程の出発原料としてもよいが、単離、精製する
ことなく次の工程に供しても何ら支障がなく、むしろ実
際の工業生産においてはそのまま次の工程に供した方が
操作が簡便で好ましい。The above-mentioned general formula (I
The benzyl succinic acid derivative represented by V) may be isolated and purified to be used as a starting material for the next step, but it can be used in the next step without isolation and purification without causing any problem, and in fact In industrial production, it is preferable that the product is directly subjected to the next step because the operation is simple.
【0026】本製造方法において使用される原料の前記
式(VI)で表されるベンジルコハク酸は文献記載の公
知化合物であり、公知の方法に従って容易に入手するこ
とができる。〔ジャーナル オブ ザ ケミカル ソサ
イアティー パーキン トランザクション I (J.
Chem.Soc.PERKIN TRANS.I)1
989年、1571ページ〕The benzyl succinic acid represented by the above formula (VI) used as the starting material in the present production method is a known compound described in the literature and can be easily obtained by a known method. [Journal of the Chemical Society Perkin Transaction I (J.
Chem. Soc. PERKIN TRANS. I) 1
989, page 1571]
【0027】本製造方法の前記一般式(VII)で表さ
れるベンジルコハク酸誘導体の製造において、用いるこ
とができる縮合剤としては、塩化チオニル、塩化オキザ
リル、三塩化リン、五塩化リン、オキシ塩化リン、ジク
ロロメチルメチルエーテル、ホスゲン、臭化チオニル、
臭化オキザリル等のハロゲン化剤、N,N’−ジシクロ
ヘキシルカルボジイミド、1−(3−ジメチルアミノプ
ロピル)−3−エチルカルボジイミド塩酸塩のような通
常のペプチド合成に使用されるカップリング試薬等をあ
げることができる。As the condensing agent which can be used in the production of the benzylsuccinic acid derivative represented by the above general formula (VII) of the present production method, thionyl chloride, oxalyl chloride, phosphorus trichloride, phosphorus pentachloride, oxychloride can be used. Phosphorus, dichloromethyl methyl ether, phosgene, thionyl bromide,
Examples include halogenating agents such as oxalyl bromide, N, N′-dicyclohexylcarbodiimide, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride, and other coupling reagents used in ordinary peptide synthesis. be able to.
【0028】また、塩基性物質としてはトリエチルアミ
ン、ピリジン、N−メチルモルホリンなどの有機第三級
塩基をあげることができ、不活性溶媒としては酢酸エチ
ル、塩化メチレン、アセトニトリル、トルエン、1,2
−ジクロロエタン、テトラヒドロフランなどの不活性有
機溶媒をあげることができる。The basic substance may be an organic tertiary base such as triethylamine, pyridine or N-methylmorpholine, and the inert solvent may be ethyl acetate, methylene chloride, acetonitrile, toluene, 1,2.
An inert organic solvent such as dichloroethane or tetrahydrofuran can be used.
【0029】本製造方法を好適に実施するには、前記式
(VI)で表されるベンジルコハク酸に対し4倍モルの
N−ヒドロキシスクシンイミドおよび4倍モルのトリエ
チルアミンの混合物に、−30℃にて2倍モルの塩化チ
オニルを滴下し撹拌後、前記式(VI)で表わされるベ
ンジルコハク酸を加え、徐々に室温に戻し、室温で反応
したのち、氷冷下に等モルの前記式(III)で表され
る環状アミンを滴下し、室温で反応する。反応混合物に
1規定の水酸化ナトリウム水溶液を加え室温で数時間撹
拌後、有機溶媒を加え、水層を分離する。水層を希塩酸
により酸性として前記式(I)で表わされるコハク酸誘
導体を得、必要に応じ、塩に変換し再結晶する。本製造
方法は、各工程において収率が高くさらに操作も極めて
簡便であり、各工程毎の単離、精製も特に必要とせず、
しかも光学純度の高い目的物を得ることができるなど、
工業的製法として極めて好適な方法である。In order to suitably carry out the present production method, a mixture of 4 times mol of N-hydroxysuccinimide and 4 times mol of triethylamine to benzylsuccinic acid represented by the above formula (VI) is added to -30 ° C. Then, a 2-fold molar amount of thionyl chloride is added dropwise and stirred, and then benzyl succinic acid represented by the above formula (VI) is added, and the mixture is gradually returned to room temperature and reacted at room temperature. ) A cyclic amine represented by the formula (1) is added dropwise and the reaction is carried out at room temperature. A 1N aqueous sodium hydroxide solution is added to the reaction mixture, the mixture is stirred at room temperature for several hours, an organic solvent is added, and the aqueous layer is separated. The aqueous layer is acidified with dilute hydrochloric acid to obtain the succinic acid derivative represented by the above formula (I), and if necessary, converted to a salt and recrystallized. This production method has a high yield in each step and is extremely easy to operate, and does not particularly require isolation or purification in each step.
Moreover, it is possible to obtain the target product with high optical purity.
This is a very suitable method as an industrial manufacturing method.
【0030】[0030]
【発明の作用効果】本発明の製造方法は、血糖低下作用
を有し、糖尿病治療薬として有用な前記一般式(I)で
表されるベンジルコハク酸誘導体を簡便に、しかも光学
純度の高い目的物を収率よく製造することができ、工業
的製造方法として極めて有用である。EFFECTS OF THE INVENTION The production method of the present invention is capable of easily producing a benzyl succinic acid derivative represented by the above-mentioned general formula (I), which has a blood glucose lowering action and is useful as a therapeutic drug for diabetes, and has a high optical purity. The product can be produced in high yield and is extremely useful as an industrial production method.
【0031】[0031]
【実施例】本発明の内容を以下の参考例および実施例で
さらに詳細に説明する。なお、各参考例および実施例中
の化合物の融点はすべて未補正である。EXAMPLES The contents of the present invention will be described in more detail with reference to the following reference examples and examples. The melting points of the compounds in Reference Examples and Examples are all uncorrected.
【0032】参考例 1 (S)−ベンジルコハク酸ジスクシンイミジル (S)−ベンジルコハク酸2.1g(10mmol)と
N,N’−ジスクシンイミジルカルボネート5.7g
(22mmol)を乾燥アセトニトリル30mlに懸濁
させ、ピリジン1.8ml(22mmol)を滴下し、
室温で一夜撹拌した。溶媒を減圧下に留去して、残渣を
塩化メチレンに溶かし、水で洗浄した。無水硫酸ナトリ
ウムで乾燥後、溶媒を減圧留去し、得られた結晶を酢酸
エチル−ジエチルエーテルより再結晶し、(S)−ベン
ジルコハク酸ジスクシンイミジル3.9g(97%)を
白色結晶として得た。Reference Example 1 Disuccinimidyl (S) -benzylsuccinate 2.1 g (10 mmol) of (S) -benzylsuccinate and 5.7 g of N, N'-disuccinimidyl carbonate
(22 mmol) was suspended in 30 ml of dry acetonitrile, 1.8 ml (22 mmol) of pyridine was added dropwise,
Stir overnight at room temperature. The solvent was evaporated under reduced pressure, the residue was dissolved in methylene chloride and washed with water. After drying over anhydrous sodium sulfate, the solvent was evaporated under reduced pressure, and the obtained crystals were recrystallized from ethyl acetate-diethyl ether to give 3.9 g (97%) of (S) -disuccinimidyl benzylsuccinate as white crystals. Got as.
【0033】融 点: 159℃ H−NMR(CDCl3) δ:2.8〜2.9(9H,m),3.04(1H,d
d,J=7.6,17.4Hz),3.07(1H,d
d,J=7.4,14.1Hz),3.30(1H,d
d,J=6.3,14.1Hz),3.53(1H,
m),7.2〜7.4(5H,m) IR(KBr):1812,1791,1738cm1 MS(m/e):403(M+H)+,288 元素分析値(C19H18N2O8として) 計算値 C;56.72 H;4.51 N;
6.96% 分析値 C;56.40 H;4.34 N;
6.90% 〔α〕D 25 −1.6゜(c=1.0, クロロ
ホルム)Melting point: 159 ° C. H-NMR (CDCl 3 ) δ: 2.8 to 2.9 (9H, m), 3.04 (1H, d
d, J = 7.6, 17.4 Hz), 3.07 (1H, d
d, J = 7.4, 14.1 Hz), 3.30 (1H, d
d, J = 6.3, 14.1 Hz), 3.53 (1H,
m), 7.2-7.4 (5H, m) IR (KBr): 1812, 1791, 1738 cm 1 MS (m / e): 403 (M + H) + , 288 Elemental analysis value (C 19 H 18 N 2). O 8) calculated value C; 56.72 H; 4.51 N;
6.96% analytical value C; 56.40 H; 4.34 N;
6.90% [α] D 25 -1.6 ° (c = 1.0, chloroform)
【0034】参考例 2 (S)−ベンジルコハク酸 ビス(5−ノルボルネン−
2,3−ジカルボキシイミジル) N−ヒドロキシ−5
−ノルボルネン−2,3−ジカルボキシイミド8.0g
(44mmol)を乾燥塩化メチレン30mlに溶か
し、トリエチルアミン0.2ml(44mmol)を加
え、氷冷撹拌下に、塩化チオニル1.62ml(22m
mol)の乾燥塩化メチレン10mlの溶液を滴下し
た。氷冷で1時間撹拌後、(S)−ベンジルコハク酸
2.1g(10mmol)を加え徐々に室温に戻し一夜
撹拌した。水、飽和炭酸水素ナトリウム水溶液で洗浄し
た。無水硫酸ナトリウムで乾燥後、溶媒を減圧留去し得
られた結晶を酢酸エチル−ヘキサンより再結晶し、
(S)−ベンジルコハク酸 ビス(5−ノルボルネン−
2,3−ジカルボキシイミジル)4.74g(88%)
を白色結晶として得た。Reference Example 2 (S) -Benzylsuccinic acid Bis (5-norbornene-)
2,3-dicarboxyimidyl) N-hydroxy-5
-Norbornene-2,3-dicarboximide 8.0 g
(44 mmol) was dissolved in 30 ml of dry methylene chloride, 0.2 ml (44 mmol) of triethylamine was added, and 1.62 ml (22 m of thionyl chloride was stirred under ice cooling.
(10 mol) of a dry methylene chloride solution was added dropwise. After stirring with ice cooling for 1 hour, 2.1 g (10 mmol) of (S) -benzylsuccinic acid was added, and the mixture was gradually warmed to room temperature and stirred overnight. It was washed with water and saturated aqueous sodium hydrogen carbonate solution. After drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure and the obtained crystals were recrystallized from ethyl acetate-hexane,
(S) -Benzyl succinic acid bis (5-norbornene-
2,3-Dicarboxyimidyl) 4.74 g (88%)
Was obtained as white crystals.
【0035】融 点:220℃ H−NMR(CDCl3) δ:1.55(2H,d,J=9.0Hz),1.80
(2H,dd,J=1.3,8.9Hz),2.74
(1H,dd,J=6.9,17.4Hz),2.96
(1H,dd,J=7.0,17.4Hz),3.07
(1H,dd,J=7.0,14.0Hz),3.24
(1H,dd,J=6.4,14.1Hz),3.34
(4H,s),3.4〜3.5(5H,m),6.22
(2H,s),6.23(2H,s),7.2〜7.4
(5H,m) IR(KBr): 1828,1817,1780,1
733cm−1 MS(m/e): 531(M+H)+ 元素分析値(C29H26N28Oとして) 計算値 C;65.65 H;4.94 N;
5.28% 分析値 C;65.42 H;5.03 N;
5.21% 〔α〕D 25 +1.5゜ (c=1.0, クロ
ロホルム)Melting point: 220 ° C. H-NMR (CDCl 3 ) δ: 1.55 (2H, d, J = 9.0 Hz), 1.80
(2H, dd, J = 1.3, 8.9Hz), 2.74
(1H, dd, J = 6.9, 17.4Hz), 2.96
(1H, dd, J = 7.0, 17.4Hz), 3.07
(1H, dd, J = 7.0, 14.0 Hz), 3.24
(1H, dd, J = 6.4, 14.1 Hz), 3.34
(4H, s), 3.4 to 3.5 (5H, m), 6.22
(2H, s), 6.23 (2H, s), 7.2 to 7.4
(5H, m) IR (KBr): 1828, 1817, 1780, 1
733 cm −1 MS (m / e): 531 (M + H) + elemental analysis value (as C 29 H 26 N 28 O) calculated value C; 65.65 H; 4.94 N;
5.28% analytical value C; 65.42 H; 5.03 N;
5.21% [α] D 25 + 1.5 ° (c = 1.0, chloroform)
【0036】実施例 1 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸スクシン
イミジル (S)−ベンジルコハク酸ジスクシンイミジル402m
g(1mmol)を乾燥塩化メチレン6mlに溶かし、
氷冷撹拌下にシス−ヘキサヒドロイソインドリン125
mg(1mmol)を乾燥塩化メチレン1mlに溶かし
た溶液を滴下した。一夜室温で撹拌した後、水で洗浄
し、無水硫酸ナトリウムで乾燥した。減圧下に溶媒を留
去し、(S)−2−ベンジル−3−(シス−ヘキサヒド
ロ−2−イソインドリニルカルボニル)プロピオン酸ス
クシンイミジル371mg(90%)を無色油状物とし
て得た。Example 1 (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) succinimidyl (S) -benzyl disuccinimidyl succinate 402m
g (1 mmol) was dissolved in 6 ml of dry methylene chloride,
Cis-hexahydroisoindoline 125 under ice-cooled stirring
A solution of mg (1 mmol) dissolved in 1 ml of dry methylene chloride was added dropwise. After stirring overnight at room temperature, it was washed with water and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to obtain 371 mg (90%) of succinimidyl (S) -2-benzyl-3- (cis-hexahydro-2-isoindolinylcarbonyl) propionate as a colorless oil.
【0037】H−NMR(CDCl3) δ:1.3〜1.6(8H,m),2.1〜2.3(2
H,m),2.42(1H,dd,J=6.4,16.
3Hz),2.6〜3.9(12H,m),7.1〜
7.4(5H,m) IR(neat):1812,1783,1740,1
638,1450cm−1 MS(m/e): 413(M+H)+ 〔α〕D 25 +4.2゜(c=0.65,クロロ
ホルム)H-NMR (CDCl 3 ) δ: 1.3 to 1.6 (8H, m), 2.1 to 2.3 (2)
H, m), 2.42 (1H, dd, J = 6.4, 16.
3 Hz), 2.6 to 3.9 (12 H, m), 7.1 to
7.4 (5H, m) IR (neat): 1812,1783,1740,1
638,1450 cm -1 MS (m / e): 413 (M + H) + [α] D 25 + 4.2 ° (c = 0.65, chloroform)
【0038】実施例 2 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸 5−ノ
ルボルネン−2,3−ジカルボキシイミジル (S)−ベンジルコハク酸 ビス(5−ノルボルネン−
2,3−ジカルボキシイミジル531mg(1mmo
l)を乾燥塩化メチレン6mlに溶かし、氷冷撹拌下
に、シス−ヘキサヒドロイソインドリン125mg(1
mmol)の乾燥塩化メチレン1ml溶液を滴下した。
一夜室温で撹拌した後、飽和炭酸水素ナトリウム水溶液
で洗浄し、無水硫酸ナトリウムで乾燥した。減圧下に溶
媒を留去し、(S)−2−ベンジル−3−(シス−ヘキ
サヒドロ−2−イソインドリニルカルボニル)プロピオ
ン酸 5−ノルボルネン−2,3−ジカルボキシイミジ
ル447mg(94%)を無色油状物として得た。Example 2 (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) propionic acid 5-norbornene-2,3-dicarboxyimidyl (S) -benzyl succinic acid bis (5-norbornene-
5,3-Dicarboxyimidyl 531 mg (1 mmo
l) was dissolved in 6 ml of dry methylene chloride, and 125 mg of cis-hexahydroisoindoline (1
a solution of 1 mmol of dry methylene chloride in 1 ml) was added dropwise.
After stirring overnight at room temperature, the mixture was washed with saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and (S) -2-benzyl-3- (cis-hexahydro-2-isoindolinylcarbonyl) propionic acid 5-norbornene-2,3-dicarboxyimidyl 447 mg (94%). Was obtained as a colorless oil.
【0039】H−NMR(CDCl3) δ:1.3〜1.6(9H,m),1.77(1H,
d,J=9.0Hz),2.1〜2.7(2H,m),
2.3〜2.4(1H,m),2.5〜2.7(1H,
m),2.9〜3.0(1H,m),3.09(1H,
dd,J=6.3,98Hz),3.1〜3.5(8
H,m),3.60(1H,m),6.19(2H,
s),7.2〜7.3(5H,m) IR(neat):1808,1777,1738,1
642,1450cm−1 MS(m/e)= 476(M+),206 〔α〕D 25 +1.1゜(c=1.0,クロロホル
ム)H-NMR (CDCl 3 ) δ: 1.3-1.6 (9H, m), 1.77 (1H,
d, J = 9.0 Hz), 2.1 to 2.7 (2H, m),
2.3-2.4 (1H, m), 2.5-2.7 (1H,
m), 2.9 to 3.0 (1H, m), 3.09 (1H,
dd, J = 6.3, 98 Hz), 3.1-3.5 (8
H, m), 3.60 (1H, m), 6.19 (2H,
s), 7.2-7.3 (5H, m) IR (neat): 1808, 1777, 1738, 1
642,1450 cm −1 MS (m / e) = 476 (M + ), 206 [α] D 25 + 1.1 ° (c = 1.0, chloroform)
【0040】実施例 3 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸スクシン
イミジル133mg(0.32mmol)をメタノール
5mlに溶かし、1規定水酸化ナトリウム水溶液0.5
mlを加え、3時間撹拌した。減圧下に溶媒を留去し、
酢酸エチルを加えた。飽和炭酸水素ナトリウム水溶液で
2回抽出し、酢酸エチルで1回洗浄した。水層を濃塩酸
で酸性とし、塩化メチレンで2回抽出した。水で1回洗
浄し、無水硫酸マグネシウムで乾燥した。減圧下に溶媒
を留去し、油状の(S)−2−ベンジル−3−(シス−
ヘキサヒドロ−2−イソインドリニルカルボニル)プロ
ピオン酸50mg(49%)を得た。Example 3 (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) propionic acid (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) succinimidyl propionate 133 mg (0.32 mmol) was dissolved in methanol 5 ml, and 1N sodium hydroxide aqueous solution 0.5
ml was added and stirred for 3 hours. The solvent was distilled off under reduced pressure,
Ethyl acetate was added. It was extracted twice with a saturated aqueous sodium hydrogen carbonate solution and washed once with ethyl acetate. The aqueous layer was acidified with concentrated hydrochloric acid and extracted twice with methylene chloride. It was washed once with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and oily (S) -2-benzyl-3- (cis-
Hexahydro-2-isoindolinylcarbonyl) propionic acid 50 mg (49%) was obtained.
【0041】H−NMR(CDCl3) δ:1.15〜17(8H,m),2.05〜2.3
(2H,m),2.35〜2.55(2H,m),2.
65〜3.5(7H,m),7.1〜7.4(5H,
m) IR(neat): 1735,1605cm−1 〔α〕D 25 −15.4°(c=5.76,クロ
ロホルム)H-NMR (CDCl 3 ) δ: 1.15 to 17 (8H, m), 2.05 to 2.3
(2H, m), 2.35 to 2.55 (2H, m), 2.
65-3.5 (7H, m), 7.1-7.4 (5H,
m) IR (neat): 1735, 1605 cm -1 [α] D 25 -15.4 ° (c = 5.76, chloroform).
【0042】実施例 4 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸 N−ヒドロキシスクシンイミド461mg(4.0mm
ol)、トリエチルアミン560μl(4.0mmo
l)を乾燥アセトニトリル10mlに懸濁し、−30℃
に冷却した。撹拌下、塩化チオニル146μl(2.0
mmol)を滴下した。30分後、(S)−ベンジルコ
ハク酸208mg(1.0mmol)を加え、徐々に室
温に戻しながら一夜撹拌した。氷冷下にトリエチルアミ
ン140μl(1.gmmol)、シス−ヘキサヒドロ
−2−イソインドリン塩酸塩162mg(1.0mmo
l)を加え、徐々に室温に戻しながらさらに一夜撹拌し
た。1規定水酸化ナトリウム水溶液を加えて4時間撹拌
した後、減圧下に溶媒を留去した。酢酸エチルを加え、
0.5規定塩酸で1回洗浄した後、1規定水酸化ナトリ
ウム水溶液で2回抽出し、酢酸エチルで1回洗浄した。
水層を濃塩酸で酸性とし、塩化メチレンで2回抽出し
た。水で1回洗浄し、無水硫酸マグネシウムで乾燥し
た。減圧下に溶媒を留去し、油状の(S)−2−ベンジ
ル−3−(シス−ヘキサヒドロ−2−イソインドリニル
カルボニル)プロピオン酸235mg(75%)を得
た。物性値は実施例3で得たサンプルと一致した。Example 4 (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) propionic acid N-hydroxysuccinimide 461 mg (4.0 mm)
ol), 560 μl of triethylamine (4.0 mmo
l) is suspended in 10 ml of dry acetonitrile and -30 ° C.
Cooled to. With stirring, 146 μl of thionyl chloride (2.0 μl
mmol) was added dropwise. After 30 minutes, 208 mg (1.0 mmol) of (S) -benzylsuccinic acid was added, and the mixture was stirred overnight while gradually returning to room temperature. 140 μl (1. gmmol) of triethylamine and 162 mg (1.0 mmo) of cis-hexahydro-2-isoindoline hydrochloride under ice cooling.
1) was added, and the mixture was further stirred overnight while gradually returning to room temperature. After adding 1N aqueous sodium hydroxide solution and stirring for 4 hours, the solvent was distilled off under reduced pressure. Add ethyl acetate,
After washing once with 0.5N hydrochloric acid, the mixture was extracted twice with a 1N aqueous sodium hydroxide solution and washed once with ethyl acetate.
The aqueous layer was acidified with concentrated hydrochloric acid and extracted twice with methylene chloride. It was washed once with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 235 mg (75%) of oily (S) -2-benzyl-3- (cis-hexahydro-2-isoindolinylcarbonyl) propionic acid. The physical property values were in agreement with those of the sample obtained in Example 3.
【0043】実施例 5 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸 5−ノ
ルボルネン−2,3−ジカルボキシイミジル50mg
(0.1mmol)をメタノール1mlに溶かし、1規
定水酸化ナトリウム水溶液0.5mlを加え、2時間攪
拌した。減圧下に溶媒を留去し、酢酸エチルを加えた。
0.5規定水酸化ナトリウム水溶液で2回抽出し、水層
を濃塩酸で酸性とした後、塩化メチレンで2回抽出し
た。無水硫酸マグネシウムで乾燥後、溶媒を減圧下に留
去し、油状の(S)−2−ベンジル−3−(シス−ヘキ
サヒドロ−2−イソインドリニルカルボニル)プロピオ
ン酸30mg(91%)を得た。物性値は実施例3で得
たサンプルと一致した。Example 5 (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) propionic acid (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) propionic acid 5-norbornene-2,3-dicarboximidyl 50 mg
(0.1 mmol) was dissolved in 1 ml of methanol, 0.5 ml of 1N aqueous sodium hydroxide solution was added, and the mixture was stirred for 2 hours. The solvent was distilled off under reduced pressure, and ethyl acetate was added.
The mixture was extracted twice with 0.5N aqueous sodium hydroxide solution, the aqueous layer was acidified with concentrated hydrochloric acid, and then extracted twice with methylene chloride. After drying over anhydrous magnesium sulfate, the solvent was evaporated under reduced pressure to obtain 30 mg (91%) of oily (S) -2-benzyl-3- (cis-hexahydro-2-isoindolinylcarbonyl) propionic acid. . The physical property values were in agreement with those of the sample obtained in Example 3.
【0044】実施例 6 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸カルシウ
ム・二水和物 (S)−2−ベンジル−3−(シス−ヘキサヒドロ−2
−イソインドリニルカルボニル)プロピオン酸4.04
gをエタノール15mlに溶解し、2規定水酸化ナトリ
ウム水溶液6.4mlを加え濃縮乾固した。残渣を水3
0mlに溶解し、激しく攪拌しながら塩化カルシウム
2.84gの10ml水溶液を滴下した。1時間攪拌し
た後、クロロホルムで抽出し、水洗後、無水硫酸ナトリ
ウムで乾燥し減圧濃縮した。残渣を5%含水エタノール
50mlに溶解し、一晩放置した。析出する結晶をろ
取、乾燥し、(S)−2−ベンジル−3−(シス−ヘキ
サヒドロ−2−イソインドリニルカルボニル)プロピオ
ン酸カルシウム・二水和物4.1gを得た。Example 6 (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) calcium propionate dihydrate (S) -2-benzyl-3- (cis-hexahydro-2
-Isoindolinylcarbonyl) propionic acid 4.04
g was dissolved in 15 ml of ethanol, 6.4 ml of 2N sodium hydroxide aqueous solution was added, and the mixture was concentrated to dryness. The residue is water 3
It was dissolved in 0 ml, and a 10 ml aqueous solution of 2.84 g of calcium chloride was added dropwise with vigorous stirring. After stirring for 1 hour, the mixture was extracted with chloroform, washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was dissolved in 50 ml of 5% hydrous ethanol and left overnight. The precipitated crystals were collected by filtration and dried to obtain 4.1 g of (S) -2-benzyl-3- (cis-hexahydro-2-isoindolinylcarbonyl) propionate calcium dihydrate.
【0045】融 点: 179〜185℃ H−NMR(CDCl3) δ:1.15〜1.5(16H,m),1.9〜2.4
(6H,m),2.55〜3.1(14H,m),3.
2〜3.5(6H,m),7.1〜7.3(10H,
m) IR(KBr):νCO 1660,1625cm−1 〔α〕D 17.5 +5.7゜(c=1.0,メ
タノールMelting point: 179 to 185 ° C. H-NMR (CDCl 3 ) δ: 1.15 to 1.5 (16 H, m), 1.9 to 2.4
(6H, m), 2.55-3.1 (14H, m), 3.
2 to 3.5 (6H, m), 7.1 to 7.3 (10H,
m) IR (KBr): νCO 1660, 1625 cm −1 [α] D 17.5 + 5.7 ° (c = 1.0, methanol)
Claims (2)
レン基またはビシクロ〔2,2,1〕ヘプタ−5−エン
−2,3−ジイル基であり、(S)を付した炭素原子の
配置はS配置を示す)で表されるベンジルコハク酸誘導
体を加水分解することを特徴とする、式 【化2】 (式中の(S)を付した炭素原子の配置はS配置を示
す)で表されるベンジルコハク酸誘導体の製造方法。1. A general formula: (A in the formula is an ethylene group, a trimethylene group, an o-phenylene group or a bicyclo [2,2,1] hept-5-ene-2,3-diyl group, and the arrangement of the carbon atom with (S) Represents the S configuration) and hydrolyzes a benzyl succinic acid derivative represented by the formula: A method for producing a benzyl succinic acid derivative represented by (the arrangement of carbon atoms with (S) in the formula indicates the S arrangement).
レン基またはビシクロ〔2,2,1〕ヘプタ−5−エン
−2,3−ジイル基であり、(S)を付した炭素原子の
配置はS配置を示す)で表されるベンジルコハク酸誘導
体。2. A general formula: (A in the formula is an ethylene group, a trimethylene group, an o-phenylene group or a bicyclo [2,2,1] hept-5-ene-2,3-diyl group, and the arrangement of the carbon atom with (S) Represents the S configuration), and is a benzyl succinic acid derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16585293A JP3207017B2 (en) | 1993-05-28 | 1993-05-28 | Method for producing benzylsuccinic acid derivative and intermediate for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16585293A JP3207017B2 (en) | 1993-05-28 | 1993-05-28 | Method for producing benzylsuccinic acid derivative and intermediate for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06340622A true JPH06340622A (en) | 1994-12-13 |
JP3207017B2 JP3207017B2 (en) | 2001-09-10 |
Family
ID=15820224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16585293A Expired - Lifetime JP3207017B2 (en) | 1993-05-28 | 1993-05-28 | Method for producing benzylsuccinic acid derivative and intermediate for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3207017B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032736A1 (en) * | 1997-01-29 | 1998-07-30 | Kissei Pharmaceutical Co., Ltd. | Process for producing benzylsuccinic acid derivatives |
WO1999052876A1 (en) * | 1998-04-15 | 1999-10-21 | Sanofi-Synthelabo | Azacycloalkane derivatives, preparation and therapeutic application |
JP2007176824A (en) * | 2005-12-27 | 2007-07-12 | Kissei Pharmaceut Co Ltd | Asymmetric reduction method |
ITMI20121347A1 (en) * | 2012-07-31 | 2014-02-01 | Olon Spa | EFFICIENT METHOD FOR THE PREPARATION OF MITIGLINID WITH HIGH PURITY |
JP2014034521A (en) * | 2012-08-07 | 2014-02-24 | Tokuyama Corp | Method for producing crystal of mitiglinide calcium hydrate |
-
1993
- 1993-05-28 JP JP16585293A patent/JP3207017B2/en not_active Expired - Lifetime
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032736A1 (en) * | 1997-01-29 | 1998-07-30 | Kissei Pharmaceutical Co., Ltd. | Process for producing benzylsuccinic acid derivatives |
WO1999052876A1 (en) * | 1998-04-15 | 1999-10-21 | Sanofi-Synthelabo | Azacycloalkane derivatives, preparation and therapeutic application |
FR2777566A1 (en) * | 1998-04-15 | 1999-10-22 | Synthelabo | AZACYCLOALCANES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
JP2007176824A (en) * | 2005-12-27 | 2007-07-12 | Kissei Pharmaceut Co Ltd | Asymmetric reduction method |
WO2007077818A1 (en) * | 2005-12-27 | 2007-07-12 | Kissei Pharmaceutical Co., Ltd. | Asymmetric reduction method |
US7847107B2 (en) | 2005-12-27 | 2010-12-07 | Kissei Pharmaceutical Co., Ltd. | Asymmetric reduction method |
KR101437078B1 (en) * | 2005-12-27 | 2014-09-02 | 깃세이 야쿠힌 고교 가부시키가이샤 | Asymmetric reduction method |
ITMI20121347A1 (en) * | 2012-07-31 | 2014-02-01 | Olon Spa | EFFICIENT METHOD FOR THE PREPARATION OF MITIGLINID WITH HIGH PURITY |
JP2014034521A (en) * | 2012-08-07 | 2014-02-24 | Tokuyama Corp | Method for producing crystal of mitiglinide calcium hydrate |
Also Published As
Publication number | Publication date |
---|---|
JP3207017B2 (en) | 2001-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004110974A1 (en) | Matrix metalloproteinase inhibitors | |
TW200305559A (en) | Process for trans-4-amino-1-cyclohexane carboxylic acid derivatives | |
JP3207017B2 (en) | Method for producing benzylsuccinic acid derivative and intermediate for producing the same | |
JP3207018B2 (en) | Method for producing benzylsuccinic acid derivative and intermediate for producing the same | |
JP2820739B2 (en) | Method for producing carbostyril derivatives | |
US5663365A (en) | Process for the preparation of pyrazolones | |
JP3193597B2 (en) | Method for producing glycine derivative | |
KR910005230B1 (en) | Process for producing azetidinones | |
JPH0812658A (en) | Production of sydnones | |
JP3216673B2 (en) | Method for producing 3-hydroxyisoxazole | |
JPH10287650A (en) | Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
JP3740783B2 (en) | Process for producing 4- (2-alkenyl) -2,5-oxazolidinediones | |
JP2640622B2 (en) | Method for producing progourmetasin | |
JPH07267950A (en) | Process for producing 5-chloro-N- (4,5-dihydro-1H-imidazol-2-yl) -2,1,3-benzothiadiazol-4-amine or acid addition salt thereof | |
JP3013760B2 (en) | Method for producing 4-hydroxy-2-pyrrolidone | |
JPH0427977B2 (en) | ||
JP3719736B2 (en) | Method for producing pyrazolones | |
JPH07258234A (en) | Production of 1,3,4-oxadiazole-2(3h)-thione compound | |
JPH06184054A (en) | 5-(4-@(3754/24)ethoxycarbonyl)oxy-3-methoxyphenyl)-2,4-pentadienoic acid chloride and its production | |
JPS58164573A (en) | Manufacture of 1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-3-indole acetoxyacetic acids | |
JPH0881427A (en) | ((4-substituted acetyl-ortho--phenylene)dioxy) diacetic acid derivative and its production | |
JPS6126902B2 (en) | ||
JPS6254310B2 (en) | ||
JPH0569825B2 (en) | ||
JP2001328993A (en) | Optically active phosphine compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 7 Free format text: PAYMENT UNTIL: 20080706 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080706 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090706 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 9 Free format text: PAYMENT UNTIL: 20100706 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20110706 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20120706 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120706 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20130706 |
|
EXPY | Cancellation because of completion of term |